Guidance for the Development of Vaginal Contraceptive Drugs (NDA)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 2, 1998
March 20, 2019
274b67c2-e9a6-4c70-a492-00f91e8df6dd
Related Documents
Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application
Guidance DocumentFebruary 1, 1987Center for Drug Evaluation and Research
Enforcement Policy on Marketing OTC Combination Products (CPG 7132b16)
Guidance DocumentMay 1, 1984Center for Drug Evaluation and Research
Preparation of Investigational New Drug Products (Human and Animal): Guidance for Industry
Guidance DocumentNovember 1, 1992Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox